Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study will determine the safety and efficacy of pregabalin (Lyrica) when administered by
itself (without any other anti-epileptic medication) to epilepsy subjects for the treatment
of partial seizures. The duration of the trial is about 6 months.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.